Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants-Reference-Cited by-同舟云学术

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants

Published:2022-03-16 Issue:1 Volume:14 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Kuramochi Taichi¹^ORCID,Gan Siok Wan²^ORCID,Ho Adrian W.S.²^ORCID,Wang Bei³^ORCID,Kageji Nagisa⁴,Nambu Takeru²,Iida Sayaka²,Okuda-Miura Momoko²,Chia Wei Shan²,Yeo Chiew Ying²,Chen Dan²^ORCID,Lee Wen-Hsin³^ORCID,Ngoh Eve Zi Xian³^ORCID,Mohd Salleh Siti Nazihah³^ORCID,Wang Cheng-I³^ORCID,Igawa Tomoyuki⁵,Shimada Hideaki²^ORCID

Affiliation:

1. Chugai Pharmaceutical Co. Ltd., Fuji Gotemba Research Laboratories, Komakado, Gotemba, Shizuoka, Japan

2. Chugai Pharmabody Research Pte. Ltd., Singapore

3. Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR)

4. Chugai Pharmaceutical Co. Ltd., Kamakura Research Laboratories, Kajiwara, Kamakura, Kanagawa, Japan

5. Chugai Pharmaceutical Co. Ltd., Translational Research Division, Tokyo, Japan

Funder

Chugai Pharmaceutical

Biomedical Research Council

Agency of Science, Technology and Research

Open Access publication charges for this article

Publisher